H. Trent Spencer

H. Trent Spencer

Company: Expression Therapeutics, LLC

Job title: President & Co- Founder


Ex vivo Expansion and Genetic Engineering of Gamma Delta T cells 10:00 am

• Optimized a GMP compliant, ex vivo expansion protocol that is being developed for a clinical trial to treat childhood cancer • Optimized methods to genetically engineer gamma delta T cells using transfection or viral vector transduction, including lentiviral and AAV vectorsRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.